o 129 has been researched along with cloxacillin in 1 studies
| Studies (o 129) | Trials (o 129) | Recent Studies (post-2010) (o 129) | Studies (cloxacillin) | Trials (cloxacillin) | Recent Studies (post-2010) (cloxacillin) |
|---|---|---|---|---|---|
| 30 | 0 | 2 | 1,715 | 155 | 177 |
| Protein | Taxonomy | o 129 (IC50) | cloxacillin (IC50) |
|---|---|---|---|
| Beta-lactamase | Escherichia coli | 0.026 | |
| Efflux transporter | Salmonella enterica subsp. enterica serovar Newport | 0.004 | |
| Beta-lactamase | Klebsiella pneumoniae | 0.004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batra, HV; Kingston, JJ; Kumar, S; Tuteja, U; Zachariah, K | 1 |
1 other study(ies) available for o 129 and cloxacillin
| Article | Year |
|---|---|
Molecular characterization of Vibrio cholerae isolates from cholera outbreaks in North India.
Topics: Anti-Bacterial Agents; Cholera; Cloxacillin; Disease Outbreaks; DNA Fingerprinting; Endopeptidases; Fimbriae Proteins; Furazolidone; Genes, Bacterial; Humans; India; Microbial Sensitivity Tests; Nalidixic Acid; Polymyxin B; Pteridines; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae O1 | 2009 |